Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 281: Which of the following tumors is typically found incidentally during investigations?

A. Hemangioma (Correct Answer)
B. Adenoma
C. Hamartoma
D. Lymphoma

Explanation: **Explanation:** **Cavernous Hemangioma** is the most common benign tumor of the liver. It is typically a small, solitary lesion composed of blood-filled endothelial-lined spaces. The vast majority of hemangiomas are asymptomatic and do not undergo malignant transformation; therefore, they are most frequently discovered **incidentally** during abdominal imaging (USG or CT) performed for unrelated reasons. **Analysis of Options:** * **Adenoma (Option B):** While some are incidental, Hepatic Adenomas are clinically significant because they carry a risk of spontaneous rupture (causing intraperitoneal hemorrhage) and malignant transformation into Hepatocellular Carcinoma (HCC). They are strongly associated with oral contraceptive use. * **Hamartoma (Option C):** Mesenchymal hamartomas are rare benign tumors primarily seen in infants and young children. They often present as a rapidly enlarging abdominal mass rather than an incidental finding in adults. * **Lymphoma (Option D):** Primary hepatic lymphoma is extremely rare. Secondary involvement usually presents with systemic symptoms (B-symptoms), hepatomegaly, or abnormal liver function tests, making it unlikely to be a purely incidental finding. **High-Yield Clinical Pearls for NEET-PG:** * **Imaging Gold Standard:** Triple-phase CT shows **peripheral globular enhancement** with "centripetal filling" (delayed opacification toward the center). * **Management:** Most require no treatment. Surgery (enucleation or resection) is reserved only for very large ("Giant" >10cm) symptomatic lesions or those with a risk of rupture. * **Contraindication:** Percutaneous biopsy is generally avoided due to the high risk of hemorrhage. * **Kasabach-Merritt Syndrome:** A rare complication where a giant hemangioma causes consumptive coagulopathy and thrombocytopenia.

Question 282: Which of the following is not a major high-risk factor for cholangiocarcinoma?

A. Chronic typhoid
B. Choledocholithiasis (Correct Answer)
C. C. sinensis infestation
D. Ulcerative colitis

Explanation: **Explanation:** The development of cholangiocarcinoma (CCA) is strongly associated with conditions causing **chronic biliary inflammation and stasis**. **Why Choledocholithiasis is the correct answer:** While **Choledocholithiasis** (stones in the common bile duct) causes inflammation, it is generally **not** considered a major high-risk factor for cholangiocarcinoma. In contrast, **Hepatolithiasis** (intrahepatic stones) is a well-established major risk factor due to the prolonged, recurrent pyogenic cholangitis and mucosal dysplasia it induces. Simple ductal stones are common and rarely progress to malignancy compared to the other listed conditions. **Analysis of Incorrect Options:** * **Chronic Typhoid (A):** Chronic carriers of *Salmonella typhi* (especially those with gallbladder colonization) have a significantly increased risk of biliary tract cancers due to chronic bacterial irritation and the production of carcinogenic metabolites. * **C. sinensis infestation (C):** Liver flukes (*Clonorchis sinensis* and *Opisthorchis viverrini*) are Group 1 carcinogens. They cause chronic mechanical injury and inflammation of the bile duct epithelium, making them a leading cause of CCA in endemic regions (Southeast Asia). * **Ulcerative Colitis (D):** This is strongly associated with **Primary Sclerosing Cholangitis (PSC)**. PSC is the most common predisposing factor for cholangiocarcinoma in Western countries, with a lifetime risk of 10-15%. **High-Yield Facts for NEET-PG:** * **Most common site:** Perihilar (Klatskin tumor) is the most common location for CCA. * **Tumor Marker:** **CA 19-9** is the most commonly used marker for diagnosis and monitoring. * **Choledochal Cysts:** Type I and Type IV cysts carry the highest risk of malignant transformation. * **Risk Factor Mnemonic:** Remember the "S's": **S**tones (Intrahepatic), **S**clerosing Cholangitis, **S**almonella, and **S**pirit (Alcohol/Cirrhosis).

Question 283: Which of the following is the most common complication of this procedure?

A. Shunt stenosis
B. Capsular hemorrhage
C. Metabolic encephalopathy (Correct Answer)
D. Recurrent variceal bleed

Explanation: ***Metabolic encephalopathy*** - **Hepatic encephalopathy** occurs in **25-35%** of patients post-TIPS due to bypassing hepatic metabolism of **nitrogenous compounds** like ammonia. - The shunt creates a direct connection between portal and systemic circulation, reducing the liver's ability to **detoxify** blood from the GI tract. *Shunt stenosis* - While **shunt stenosis** can occur, it is typically a **delayed complication** that develops over months to years, not the most common immediate issue. - Modern **covered stent grafts** have significantly reduced the incidence of stenosis compared to bare metal stents. *Capsular hemorrhage* - **Hepatic capsular hemorrhage** is a rare procedural complication occurring in less than **2-5%** of cases during needle puncture. - It is typically **self-limiting** and managed conservatively with observation and supportive care. *Recurrent variceal bleed* - **Recurrent bleeding** can occur if the shunt becomes **stenotic** or **occluded**, but this is a secondary complication rather than primary. - TIPS is specifically designed to **reduce portal pressure** and prevent variceal rebleeding, making this less common than encephalopathy.

Question 284: What is the most common type of gallbladder carcinoma associated with gallstones?

A. Adenocarcinoma (Correct Answer)
B. Anaplastic carcinoma
C. Squamous cell carcinoma
D. Transitional cell carcinoma

Explanation: **Explanation:** **Gallbladder carcinoma (GBC)** is the most common biliary tract malignancy. The correct answer is **Adenocarcinoma** because it accounts for approximately **90-95%** of all gallbladder cancers. 1. **Why Adenocarcinoma is Correct:** The gallbladder is lined by columnar epithelium. Chronic irritation, most commonly due to **gallstones (cholelithiasis)**, leads to a sequence of metaplasia-dysplasia-carcinoma. Since the primary lining is glandular in nature, the resulting malignancy is almost always an adenocarcinoma. It can present in various forms, such as papillary, tubular, or mucinous. 2. **Why Other Options are Incorrect:** * **Anaplastic Carcinoma:** This is a rare, highly aggressive variant (approx. 2-3%) characterized by giant or spindle cells and carries a very poor prognosis. * **Squamous Cell Carcinoma:** This occurs in only 1-2% of cases. It arises from squamous metaplasia of the gallbladder lining, often due to chronic inflammation. * **Transitional Cell Carcinoma:** This is extremely rare in the gallbladder as this tissue type is characteristic of the urinary tract (urothelium). **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Gallstones are the most significant risk factor (found in 70-90% of cases). Other risks include **Porcelain Gallbladder** (intramural calcification), Choledochal cysts, and *Salmonella typhi* carrier state. * **Demographics:** It is more common in females (3:1 ratio) and shows a high prevalence in North India (Gangetic belt). * **Nevin’s Staging** and **AJCC TNM Staging** are used for prognosis. * **Investigation of Choice:** Contrast-Enhanced CT (CECT) is the gold standard for staging; Ultrasound is the initial screening tool.

Question 285: What incision approach is used for a mesocaval shunt?

A. Midline (Correct Answer)
B. Paramedian
C. Subcostal
D. Chevron

Explanation: **Explanation:** The **mesocaval shunt** is a portosystemic shunt performed to decompress portal hypertension by connecting the superior mesenteric vein (SMV) to the inferior vena cava (IVC), often using a synthetic H-graft. **Why Midline is correct:** The procedure requires extensive exposure of the retroperitoneum and the root of the mesentery. A **long midline incision** (from xiphoid to below the umbilicus) provides the best vertical access to both the SMV (located in the mesentery) and the infrarenal IVC (located retroperitoneally). It allows the surgeon to mobilize the transverse colon superiorly and the small bowel to the right to reach the vascular structures efficiently. **Why other options are incorrect:** * **Paramedian:** This incision is rarely used in modern vascular or hepatobiliary surgery as it is time-consuming to perform and offers no significant exposure advantage over the midline approach. * **Subcostal (Kocher’s):** While excellent for gallbladder or biliary tree surgery, a unilateral subcostal incision does not provide enough inferior exposure to reach the infrarenal IVC. * **Chevron (Bilateral Subcostal):** This is the gold standard for liver transplants and major hepatic resections. However, for a mesocaval shunt, the pathology is deeper in the mid-abdomen/retroperitoneum rather than the upper quadrants, making the midline incision more direct and less morbid. **High-Yield Clinical Pearls for NEET-PG:** * **Portocaval Shunt:** Usually performed via a **Right Subcostal** or **Chevron** incision (due to the high location of the portal vein). * **Distal Splenorenal Shunt (Warren Shunt):** Typically performed via a **Left Subcostal** or Midline incision. * **Indication:** Mesocaval shunts are often preferred in patients with previous upper abdominal surgery or those with a small diameter splenic vein.

Question 286: Which of the following originates at the hilum of the liver?

A. Klatskin tumor (Correct Answer)
B. Cholangiocarcinoma
C. Caroli disease
D. Primary sclerosing cholangitis

Explanation: ### Explanation **Correct Answer: A. Klatskin tumor** **Concept:** A **Klatskin tumor** is a specific type of **hilar cholangiocarcinoma**. By definition, it originates at the junction of the right and left hepatic ducts at the **hilum of the liver**. Because of its strategic location, it typically presents early with obstructive jaundice and is classified using the **Bismuth-Corlette classification** based on the extent of ductal involvement. **Why other options are incorrect:** * **B. Cholangiocarcinoma:** This is a broad, umbrella term for any cancer arising from the bile duct epithelium. It is categorized into intrahepatic, perihilar (Klatskin), and distal types. While a Klatskin tumor *is* a cholangiocarcinoma, "Cholangiocarcinoma" as a general term does not exclusively originate at the hilum. * **C. Caroli Disease:** This is a rare congenital disorder characterized by multifocal, segmental **dilatation of the intrahepatic bile ducts**. It involves the entire intrahepatic biliary tree rather than originating specifically at the hilum. * **D. Primary Sclerosing Cholangitis (PSC):** This is a chronic cholestatic liver disease characterized by inflammation and fibrosis of **both intrahepatic and extrahepatic bile ducts**. It is a diffuse process and does not "originate" at the hilum, though it is a major risk factor for developing a Klatskin tumor. **High-Yield Pearls for NEET-PG:** * **Clinical Presentation:** Progressive painless jaundice, weight loss, and a **non-distended gallbladder** (Courvoisier’s law—since the obstruction is proximal to the cystic duct). * **Imaging:** Magnetic Resonance Cholangiopancreatography (**MRCP**) is the gold standard for diagnosis and mapping the extent of the tumor. * **Bismuth-Corlette Classification:** * **Type I:** Below the confluence. * **Type II:** Reaches the confluence. * **Type IIIa/b:** Involves the confluence and the right (a) or left (b) hepatic duct. * **Type IV:** Involves both right and left secondary intrahepatic radicals.

Question 287: What is Mirrizi syndrome?

A. Cyst present in the common bile duct (CBD)
B. Stone in the cystic duct compressing the common bile duct (CBD) (Correct Answer)
C. Obstruction of the pancreatic duct
D. Stone in the right hepatic duct

Explanation: **Explanation:** **Mirizzi Syndrome** is a rare complication of chronic cholelithiasis. It occurs when a gallstone becomes impacted in the **cystic duct** or the **neck of the gallbladder (Hartmann’s pouch)**. This impacted stone causes extrinsic mechanical compression of the adjacent **Common Hepatic Duct (CHD)** or **Common Bile Duct (CBD)**, leading to obstructive jaundice. **Why Option B is correct:** The pathophysiology involves an inflammatory process triggered by the impacted stone, which can eventually lead to a cholecystobiliary fistula. The hallmark is jaundice in the presence of a stone that is technically *outside* the CBD but compressing it. **Why other options are incorrect:** * **Option A:** A cyst in the CBD refers to a **Choledochal cyst**, which is a congenital cystic dilatation of the biliary tree. * **Option C:** Obstruction of the pancreatic duct is typically associated with chronic pancreatitis or periampullary carcinoma, not Mirizzi syndrome. * **Option D:** While stones can occur in the hepatic ducts (hepatolithiasis), Mirizzi syndrome specifically involves the cystic duct/gallbladder neck obstructing the main biliary channel. **High-Yield Clinical Pearls for NEET-PG:** * **Csendes Classification:** Used to grade Mirizzi Syndrome (Type I: Simple compression; Type II-IV: Presence of cholecystobiliary fistula involving varying portions of the CBD circumference). * **Clinical Presentation:** Presents with Charcot’s triad (jaundice, fever, RUQ pain), mimicking choledocholithiasis. * **Surgical Caution:** It is a "trap" for surgeons; the intense inflammation can lead to accidental CBD injury during cholecystectomy. * **Diagnosis:** MRCP is the gold standard for non-invasive diagnosis.

Question 288: All of the following are known predisposing factors for cholangiocarcinoma except:

A. CBD stones (Correct Answer)
B. Clonorchis sinensis
C. Ulcerative colitis
D. Primary sclerosing cholangitis

Explanation: **Explanation:** The correct answer is **A. CBD stones**. While chronic irritation is a hallmark of cholangiocarcinoma (CCA) pathogenesis, simple Common Bile Duct (CBD) stones (choledocholithiasis) are generally not considered a direct independent risk factor for the development of CCA. In contrast, **intrahepatic stones (hepatolithiasis)** are strongly associated with the disease due to chronic recurrent pyogenic cholangitis. **Analysis of Options:** * **Clonorchis sinensis:** This liver fluke (along with *Opisthorchis viverrini*) is a classic risk factor. Chronic infection leads to biliary inflammation, hyperplasia, and eventual malignant transformation. * **Ulcerative Colitis (UC):** UC is indirectly linked via its strong association with Primary Sclerosing Cholangitis (PSC). Patients with UC have a significantly higher lifetime risk of developing CCA compared to the general population. * **Primary Sclerosing Cholangitis (PSC):** This is the most common predisposing factor for CCA in the Western world. About 10-15% of PSC patients will develop cholangiocarcinoma. **NEET-PG High-Yield Pearls:** * **Choledochal Cysts:** Type I and Type IV cysts carry the highest risk of malignancy; surgical excision is mandatory. * **Thorotrast:** A historical radiologic contrast agent strongly linked to CCA and Angiosarcoma of the liver. * **Tumor Marker:** **CA 19-9** is the most commonly used marker for monitoring, though it can be elevated in benign obstructive jaundice. * **Anatomy:** The most common site for CCA is the confluence of the hepatic ducts (**Klatskin Tumor**).

Question 289: Which of the following types of hydatid cyst denotes a complicated cyst?

A. Type I
B. Type II
C. Type III
D. Type IV (Correct Answer)

Explanation: The classification of hydatid cysts is primarily based on the **Gharbi Classification** (ultrasound-based), which is crucial for determining management strategies. ### **Explanation of the Correct Answer** **Type IV** cysts are characterized as **solid or heterogenous masses** with no visible internal vesicles. This appearance represents a "pseudotumor" pattern. In the context of the Gharbi classification, Types I, II, and III are considered "active" or "simple" stages of the parasite's life cycle. **Type IV and Type V** are considered **complicated or inactive/degenerate** stages. Specifically, Type IV indicates that the parasite is dying or that the cyst has undergone internal degeneration, making it a "complicated" presentation compared to the clear, fluid-filled active stages. ### **Analysis of Incorrect Options** * **Type I (Option A):** Purely fluid-filled, unilocular collection. It is an **active** cyst (simple). * **Type II (Option B):** Characterized by fluid collection with a "split wall" (detached endocyst) or "water lily sign." It is an **active** cyst. * **Type III (Option C):** Multivesicular cyst with a "honeycomb" appearance due to daughter cysts. It is an **active/transitional** cyst. ### **NEET-PG High-Yield Pearls** * **Gharbi Classification Summary:** * **Type I:** Pure fluid (Active) * **Type II:** Detached membranes (Active) * **Type III:** Daughter cysts/Honeycomb (Active) * **Type IV:** Heterogenous/Solid (Degenerative/Complicated) * **Type V:** Calcified wall (Inactive/Dead) * **Treatment Choice:** Active cysts (I-III) often require PAIR (Puncture, Aspiration, Injection, Re-aspiration) or surgery, whereas Type IV and V are often managed with "watch and wait" unless symptomatic. * **Drug of Choice:** Albendazole (10-15 mg/kg/day) is the mainstay of medical therapy.

Question 290: Contraindications for resection in cholangiocarcinoma include all except:

A. Involvement of the main trunk of the portal vein
B. Hepatic atrophy with contralateral bile duct encasement
C. Hepatic atrophy with contralateral portal vein encasement
D. Hepatic atrophy with ipsilateral bile duct involvement (Correct Answer)

Explanation: ### Explanation In the management of cholangiocarcinoma (specifically Hilar Cholangiocarcinoma or Klatskin tumors), the goal of surgery is an **R0 resection** (microscopically negative margins). Resectability is determined by the tumor's extent relative to the biliary tree and the vascular structures supplying the "future liver remnant" (FLR). **1. Why Option D is the Correct Answer:** Hepatic atrophy with **ipsilateral** (same side) bile duct involvement is **not** a contraindication. In fact, it is a common indication for a formal hemihepatectomy. If the tumor involves the right bile duct and causes right-sided hepatic atrophy, the surgeon simply resects the atrophied right lobe along with the tumor. As long as the contralateral (left) side has a patent duct, artery, and portal vein, the patient can undergo a successful resection. **2. Analysis of Contraindications (Incorrect Options):** * **Option A (Main Portal Vein Involvement):** If the main trunk of the portal vein is encased, it usually precludes a safe reconstruction and indicates advanced disease, making it a contraindication to standard resection. * **Options B & C (Atrophy with Contralateral Encasement):** These are "cross-over" signs. If the right lobe is atrophied (suggesting right-sided vascular/ductal compromise) AND the tumor involves the **contralateral** (left) portal vein or bile duct, there is no viable liver tissue left to remain after resection. This renders the tumor unresectable. **3. Clinical Pearls for NEET-PG:** * **Bismuth-Corlette Classification:** Used to grade the level of biliary involvement. Type IV (involving secondary radicals on both sides) was traditionally unresectable but is now approached with aggressive surgery in specialized centers. * **Absolute Contraindications to Resection:** * Distant metastases (M1), including N2 (celiac/para-aortic) lymph nodes. * Bilateral involvement of secondary biliary radicals. * Encasement of the main portal vein or hepatic artery. * Atrophy of one lobe with contralateral vascular or biliary encasement. * **High-Yield Fact:** The most common cause of death in unresectable cholangiocarcinoma is progressive biliary obstruction leading to sepsis and liver failure.

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free